Selected Investments
Mabworks Biotech is a clinical-stage biopharmaceutical company based in Beijing, China.The company has established fully-integrated technology platfroms in discovery and development, manufacturing and commercialization of therapeutic antibodies.
Sinobiopharma is committed to development, production and distribution of medicines for cancer, diabetes, anesthesia, muscle relaxation, analgesia, cardiovascular disease. Its current projects under research are leading the way of drug research and development in China.
Microtech is dedicated to helping people with diabetes. We develop
innovative monitoring system and therapy products that give freedom,
flexibility, and choice to our users.
iGenomX's product, Riptide is an ultra high throughput
multiplex library construction for small genomes, plasmids and gene constructs.
Each kit contains all necessary reagents to go from DNA samples to
sequencer-ready libraries for up to 960 samples.
QPEX BIOPHARMA is developing a pipeline of agents addressing critical needs for the treatment of infectious diseases in the inpatient and outpatient settings.
Shanghai Han Yu Medical
Technology Co., Ltd. is focused on the development of mitral valve
interventional medical devices company. Its core product is ValveClamp,
which is a mitral valve involved in the domestic research and
development of animal experiments.
NewMed Medical Co., Ltd. is a high-tech medical enterprise which was
established in March 2015 and located in Shanghai Medical valley PLUS,
Zhoupu Town, Pudong District, Shanghai.
Qingyun
Medical (brand name Zhi Yun Yi Lu) focuses on digital marketing of
pharmaceuticals in hospital channels. Qingyun offers customized
multi-channel marketing solutions for pharmaceutical companies with its
social customer management system integrating Wechat channels, digital
sales representatives, web conferences and online forums.
Alpha Biopharma is
supported by the domestic and foreign famous funds, and committed to the clinical
development of global innovator drug.
Chipscreen is a leading integrated biotech company specialized in discovery and development of novel small molecule pharmaceuticals.
Neurelis is a neuroscience-based specialty pharmaceutical company providing innovative approaches to target unmet medical needs. Our approach combines novel technologies designed to enhance therapeutic benefit and address gaps in patient care.